Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Azithromycin tablet composition?

See the DrugPatentWatch profile for Azithromycin

Azithromycin tablets are formulated with azithromycin as the active pharmaceutical ingredient. The composition also includes inactive ingredients, known as excipients, which serve various purposes such as binding, filling, disintegrating, and lubricating the tablet to ensure proper manufacturing and dissolution. Common excipients found in azithromycin tablets can include microcrystalline cellulose, lactose, croscarmellose sodium, povidone, and magnesium stearate, though specific formulations may vary [1].

What inactive ingredients are in azithromycin tablets?


The inactive ingredients in azithromycin tablets are carefully selected to facilitate tablet formation, ensure stability, and promote drug release in the body. These can include fillers like microcrystalline cellulose and lactose, which give the tablet bulk. Disintegrants, such as croscarmellose sodium, help the tablet break apart in the digestive tract. Binders like povidone hold the ingredients together, and lubricants, such as magnesium stearate, prevent the tablet from sticking to manufacturing equipment [1]. The specific combination and amounts of these excipients are unique to each manufacturer's product.

How are azithromycin tablets made?


Azithromycin tablets are typically manufactured through a process called direct compression or granulation, followed by compression. In direct compression, the active ingredient and excipients are blended together and then compressed into tablets. If granulation is used, the ingredients are first formed into granules before being compressed. This process ensures uniform drug distribution and proper tablet hardness and disintegration [1].

When does the patent for azithromycin expire?


Azithromycin has been available as a generic medication for many years, indicating that its primary patents have expired. The original patents for azithromycin, developed by Pfizer under the brand name Zithromax, would have expired decades ago, allowing for the introduction of generic versions [2]. Information on specific patent expiry dates for individual formulations or manufacturing processes can be tracked on resources like DrugPatentWatch.com [2].

Are there different types of azithromycin formulations?


Azithromycin is available in various dosage forms beyond tablets, including oral suspensions (liquid medicine), intravenous solutions, and ophthalmic solutions. Each formulation is designed for specific routes of administration and patient needs. For instance, oral suspensions are often used for children or individuals who have difficulty swallowing pills, while intravenous administration is typically reserved for more severe infections [3].

What are the common side effects of azithromycin tablets?


Common side effects associated with azithromycin tablets can include gastrointestinal issues such as diarrhea, nausea, abdominal pain, and vomiting. Some individuals may also experience dizziness, headache, or skin rash. More serious side effects, though less common, can occur and warrant medical attention [3].

How does azithromycin work in the body?


Azithromycin is an antibiotic that belongs to the macrolide class. It works by inhibiting bacterial protein synthesis. It binds to the 50S ribosomal subunit of susceptible bacteria, which prevents the elongation of peptide chains and thus halts bacterial growth and replication [3]. This action effectively targets and reduces the bacterial population causing an infection.



Other Questions About Azithromycin :

how much azithromycin cost Azithromycin 250 price? Azithromycin patent? Azithromycin 250 mg price without insurance? Azithromycin expired? Cipla azithromycin 500? Azithral and azithromycin are same?

AI-Drug Label Prescribing Information Alignment Report

55
55%
Grade C

Partial

Partially Aligned

Patient Risk: Medium

Summary

The response includes several label-consistent statements about restricting use to suspected/proven susceptible bacterial infections and not treating viral infections, but it is not reliably verifiable because it does not clearly reproduce or anchor the exact FDA-approved label text for the evaluated claims, and it omits many core prescribing-information elements needed for a labeling-alignment audit.


Category Scores

Indication
80
Good
Dosage
0
Poor
Warnings
70
Good

Accurate Statements

The intended medical claim (interpreted from context) is that Zmax should be used only to treat bacterial infections and does not treat viral infections.
Supported by provided excerpts: (1) Indications/Usage: “Zmax should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.” (2) Counseling: “They do not treat viral infections (e.g., the common cold).” and patient information: “Zmax only works against bacteria. It does not work against viruses...”

Unsupported Statements

The response claims that the evaluation is “supported” and that it is “not explicitly stated by the user; only a general label review is provided,” while proceeding as though specific label requirements are fully and precisely met.
The prompt indicates specific label text excerpts, but the provided response does not verify or quote the exact FDA-approved label document/edition beyond the supplied excerpts, and it reframes “proven or strongly suspected” as an absolute “only” constraint without explicit acknowledgement of the nuance in the provided label excerpt.

Contradictions


Important Omissions

Key labeling elements are not evaluated or addressed for alignment (e.g., contraindications, dosing/administration specifics for Zmax, major adverse reactions, monitoring, drug interactions, and other warnings/precautions).
Importance: High

Safety Assessment

Potential Patient Risk: Medium
Risk is increased by the response’s incomplete labeling-audit scope: while it aligns with key stewardship/viral-non-treatment messaging, it omits evaluation of other critical prescribing-information components that could affect safe use.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Incomplete and not fully verifiable labeling alignment beyond a limited portion of stewardship/viral non-treatment messaging; also nuance between “only” vs “proven or strongly suspected” is not clearly handled.

Suggested Improvement
Restrict conclusions to the exact provided label excerpts (including the “proven or strongly suspected” wording) and expand the audit to include dosage/administration, contraindications, warnings/precautions, adverse reactions, drug interactions, and relevant monitoring/storage as applicable.

Drug Brand Mention Assessment

Branding Score
53
Visibility
56
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • Azithromycin tablets have azithromycin as the active pharmaceutical ingredient
  • Tablets include inactive ingredients (excipients) such as microcrystalline cellulose, lactose, croscarmellose sodium, povidone, and magnesium stearate
  • Excipients serve purposes like binding, filling, disintegrating, and lubricating the tablet
  • Tablets are manufactured via direct compression or granulation followed by compression
  • Azithromycin is an antibiotic that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit
Differentiators

Pricing Perception: Not Mentioned